Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-30

Clinical Trial Update: Lorcaserin for Weight Loss Management in Patients on Antipsychotics: A Pilot Study [Phase 4]

View source ↗

Summary

Phase 4 pilot trial evaluating lorcaserin for weight loss management in patients taking antipsychotics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lorcaserin (lorcaserin)

Snippet

Sponsor: Southern California Institute for Research and Education | Conditions: Weight Gain | Phase 4 | Status: UNKNOWN